Transient receptor potential channels-emerging novel drug targets for the treatment of pain

Current Medicinal Chemistry

Volumn 20, Issue 11, 2013, Pages 1409-1436

  Salat, Kinga ^a   Moniczewski, Andrzej ^a   Librowski, Tadeusz ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Analgesic Drugs; Hyperthermia; Innocuous And Noxious Cold Detection; Pain Pathways; Polymodal Nociceptor; Transient Receptor Potential Family; Vanilloids

Indexed keywords

(5 TERT BUTYL 2,3 DIHYDRO 1H INDEN 1 YL) 3 (1H INDAZOL 4 YL)UREA; 1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; 1 (5 ISOQUINOLINYL) 3 [4 (TRIFLUOROMETHYL)BENZYL]UREA; 4 [3 (TRIFLUOROMETHYL) 2 PYRIDINYL] N [5 (TRIFLUOROMETHYL) 2 PYRIDINYL] 1 PIPERAZINECARBOXAMIDE; 4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; A 967079; AMG 0610; AMG 6880; AP 18; AZD 1386; CALCIUM CHANNEL BLOCKING AGENT; CAPSAICIN; CIS CAPSAICIN; GRC 6211; JTS 653; JYL 1421; MK 2295; N (1,4 BENZODIOXAN 6 YL) 3 (4 TERT BUTYLPHENYL)ACRYLAMIDE; N (4 ISOPROPYLPHENYL) 2 (1,2,3,6 TETRAHYDRO 1,3 DIMETHYL 2,6 DIOXO 7H PURIN 7 YL)ACETAMIDE; N [4 [6 [4 (TRIFLUOROMETHYL)PHENYL] 4 PYRIMIDINYLOXY]BENZOTHIAZOL 2 YL]ACETAMIDE; OLVANIL; RESINIFERATOXIN; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; TRANSIENT RECEPTOR POTENTIAL CHANNEL M8; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; VANILLOID RECEPTOR 5; VANILLOID RECEPTOR 6; VANILLOID RECEPTOR AGONIST;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTINOCICEPTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHRONIC PAIN; COUGHING; DESENSITIZATION; DIABETIC NEUROPATHY; GASTROESOPHAGEAL REFLUX; GRAY MATTER; HUMAN; INFLAMMATION; IRRITABLE COLON; ISCHEMIC PAIN; MIGRAINE; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE PAIN; NONHUMAN; PAIN; SENSITIZATION; SPINAL CORD DORSAL HORN; SPINAL GANGLION; STIMULATION; TACHYPHYLAXIS; TISSUE INJURY; TOOTH PAIN; TRANSDERMAL PATCH;

ANALGESICS; ANIMALS; HUMANS; MOLECULAR TARGETED THERAPY; PAIN; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84877935116     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/09298673113209990107     Document Type: Article

References (121)

1. Levine, J.D.; Alessandri-Haber, N. TRP channels: targets for the relief of pain. Biochim. Biophys. Acta, 2007, 1772, 989-1003.
2. Pal, M.; Angaru, S.; Kodimuthali, A.; Dhingra, N. Vanilloid receptor antagonists: emerging class of novel anti-inflammatory agents for pain management. Curr. Pharm. Des., 2009, 15, 1008-1026.
3. Andrade, E.L.; Meotti, F.C.; Calixto, J.B. TRPA1 antagonists as potential analgesic drugs. Pharmacol. Ther., 2012, 133, 189-204.
4. Trevisani, M.; Szalassi, A. Targeting TRPV1: Challenges and issues in pain management. Open Drug Discov. J., 2010, 2, 37-49.
5. Dubin, A.E.; Patapoutian, A. Nociceptors: the sensors of the pain pathway. J. Clin. Invest., 2010, 120, 3760-3772.
6. Eid, S.R.; Cortright, D.N. Transient receptor potential channels on sensory nerves. Handb. Exp. Pharmacol., 2009, 194, 261-281.
7. Voilley, N. Acid-sensing ion channels (ASICs): New targets for the analgesic effects of non-steroid anti-inflammatory drugs (NSAIDs). Curr. Drug Targets Inflamm. Allergy, 2004, 3, 71-79.
8. Julius, D.; Basbaum, A.I. Molecular mechanisms of nociception. Nature, 2001, 413, 203-210.
9. Mandadi, S.; Roufogalis, B.D ThermoTRP channels in nociceptors: Taking a lead from capsaicin receptor TRPV1. Curr. Neuropharmacol., 2008, 6, 21-38.
10. Priestley, T. Voltage-gated sodium channels and pain. Curr. Drug Targets CNS Neurol. Disord., 2004, 3, 441-456.
11. Cui, M.; Honore, P.; Zhong, C.; Gauvin, D.; Mikusa, J.; Hernandez, G.; Chandran, P.; Gomtsyan, A.; Brown, B.; Bayburt, E.K.; Marsh, K.; Bianchi, B.; McDonald, H.; Niforatos, W.; Neelands, T.R.; Moreland, R.B.; Decker, M.W.; Lee, C.H.; Sullivan, J. P.; Faltynek, C.R. TRPV1 receptors in the CNS play a key role in broad-spectrum analgesia of TRPV1 antagonist. J. Neurosci., 2006, 26, 9385-9393.
12. Adcock, J.J. TRPV1 receptors in sensitization of cough and pain reflexes. Pulm. Pharmacol. Ther., 2009, 22, 65-70.
13. Carlton, S.M. Peripheral excitatory amino acids. Curr. Opin. Pharmacol., 2001, 1, 52-56.
14. Planells-Cases, R.; Garcia-Sanz, N.; Morenilla-Palao, C.; Ferrer-Montiel, A. Functional aspects and the mechanisms of TRPV1 involvement in neurogenic inflammation that leads to thermal hyperalgesia. Eur. J. Physiol., 2005, 451, 151-159.
15. Jara-Oseguera, A.; Simon, S.A.; Rosenbaum, T. TRPV1: on the road to pain relief. Curr. Mol. Pharmacol., 2008, 1, 255-269.
16. Miyamoto, T.; Dubin, A.E.; Petrus, M.J.; Patapoutian, A. TRPV1 and TRPA1 mediate peripheral nitric oxide-induced nociception in mice. PLoS One, 2009, 4, e7596.
17. Geppetti, P.; Trevisani, M. Activation and sensitization of the vanilloid receptor: Role in gastrointestinal inflammation and function. Br. J. Pharmacol., 2004, 141, 1313-1320.
18. Cortright, D.N.; Szallasi, A. TRP channels and pain. Curr. Pharm. Des., 2009, 15, 1736-1749.
19. Joshi, N.K.; Maharaj, N.; Thomas, A. The TRPV3 receptor as a pain target: a therapeutic promise or just some more new biology? Open Drug Discov. J., 2010, 2, 89-97.
20. Chen, J.; Kim, D.; Bianchi, B.R.; Cavanaugh, E.J.; Faltynek, C.R.; Kym, P.R.; Reilly, R.M. Pore dilation occurs in TRPA1 but not in TRPM8 channels. Mol. Pain, 2009, 5, 3.
21. Caspani, O.; Zurborg, S.; Labuz, D.; Heppenstall, P.A. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS One, 2009, 4, e7383.
22. Naono-Nakayama, R.; Sunakawa, N.; Ikeda, T.; Nishimori, T. Differential effects of substance P or hemokinin-1 on transient receptor potential channels, TRPV1, TRPA1 and TRPM8, in the rat. Neuropeptides, 2010, 44, 57-61.
23. Gilron, I.; Pete, C.; Watson, N.; Cahill, C.M.; Moulin, D.E. Neuropathic pain: A practical guide for the clinician. CMAJ, 2006, 175, 265-275.
24. Xing, J.; Lu, J.; Li, J. Purinergic P2X receptors presynaptically increase glutamatergic synaptic transmission in dorsolateral periaqueductal gray. Brain Res., 2008, 1208, 46-55.
25. Miller, A.; Rabe-Jaboska, J. Leki przeciwdepresyjne w leczeniu zespoów bólowych. Farmakoterapia w Psychiatrii i Neurologii, 2005, 4, 329-342.
26. Niiyama, Y.; Kawamata, T.; Yamamoto, J.; Furuse, S.; Namiki, A. SB366791, a TRPV1 antagonist, potentiates analgesic effects of systemic morphine in a murine model of bone cancer pain. Br. J. Anaesth., 2009, 102, 251-258.
27. Burgess, G.; Williams, D. The discovery and development of analgesics: new mechanisms, new modalities. J. Clin. Invest., 2010, 120, 3753-3759.
28. Alexander, S.P.; Mathie, A.; Peters, J.A. Guide to receptors and channels (GRAC), 2nd edition (2007 revision). Br. J. Pharmacol., 2007, 150, 1-168.
29. Dietrich, A.; Chubanov, V.; Kalwa, H.; Rost, B.R.; Gudermann, T. Cation channels of the transient receptor potential subfamily: Their role in physiological and pathophysiological processes of smooth muscle cells. Pharmacol. Ther., 2006, 112, 744-760.
30. Inoue, R.; Jensen, L.J.; Shi, J.; Morita, H.; Nishida, M.; Honda, A.; Ito, Y. Transient receptor potential channels in cardiovascular function and disease. Circ. Res., 2006, 99, 119-131.
31. Messeguer, A.; Planells-Cases R.; Ferrer-Montiel, A. Physiology and pharmacology of the vanilloid receptor. Curr. Neuropharmacol., 2006, 4, 1-15.
32. Knotkova, H.; Pappagallo, M.; Szallasi, A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin. J. Pain, 2008, 24, 142-154.
33. Stucky, C.L.; Dubin, A.E.; Jeske, N.A.; Malin, S.A.; McKemy, D.D.; Story, G.M. Roles of transient receptor potential channels in pain. Brain Res. Rev., 2009, 60, 2-23.
34. Nakashimo, Y.; Takumida, M.; Fukuiri, T.; Anniko, M.; Hirakawa, K. Expression of transient receptor potential channel vanilloid (TRPV) 1-4, melastin (TRPM) 5 and 8, and ankyrin (TRPA1) in the normal and methimazole-treated mouse olfactory epithelium. Acta Otolaryngol. 2010, 130, 1278-1286.
35. Nassenstein, C.; Kwong, K.; Taylor-Clark, T.; Kollarik, M.; Macglashan, D.M.; Braun, A.; Undem, B.J. Expression and function of the ion channel TRPA1 in vagal afferent nerves innervating mouse lungs. J. Physiol., 2008, 586, 1595-1604.
36. Facer, P.; Casula, M.A.; Smith, G.D.; Benham, C.D.; Chessell, I.P.; Bountra, C.; Sinisi, M.; Birch, R.; Anand, P. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. Neurology, 2007, 7, 1-12.
37. Sherkheli, M.A.; Vogt-Eisele, A.K.; Bura, D.; Beltrán Márques, L.R.; Gisselmann, G.; Hatt, H. Characterization of selective TRPM8 ligands and their structure activity response (S.A.R) relationship. J. Pharm. Pharm. Sci., 2010, 13, 242-253.
38. Lötsch, J.; Geisslinger, G. Pharmacogenetics of new analgesics. Br. J. Pharmacol., 2011, 163, 447-460.
39. Friedrich, M.J. Research yields new insights into mechanisms and treatment of pain. JAMA, 2012, 307, 239-241.
40. Kobayashi, K.; Fukuoka, T.; Obata, K.; Yamanaka, H.; Dai, Y.; Tokunaga, A.; Noguchi, K. Distinct expression of TRPM8, TRPA1, and TRPV1 mRNAs in rat primary afferent neurons with Adelta/C-fibers and colocalization with trk receptors. J. Comp. Neurol., 2005, 493, 596-606.
41. Hiura, A. Is thermal nociception only sensed by the capsaicin receptor, TRPV1? Anat . Sci. Int., 2009, 84, 122-128.
42. Masamoto, Y.; Kawabata, F.; Fushiki, T. Intragastric administration of TRPV1, TRPV3, TRPM8, and TRPA1 agonists modulates autonomic thermoregulation in different manners in mice. Biosci. Biotechnol. Biochem., 2009, 73, 1021-1027.
43. Szallasi, A.; Cruz, F.; Geppetti, P. TRPV1: a therapeutic target for novel analgesic drugs? Trends Mol. Med., 2006, 12, 545-554.
44. Earley, S. Vanilloid and melastatin transient receptor potential channels in vascular smooth muscle. Microcirculation, 2010, 17, 237-249.
45. Baccei, M.L.; Bardoni, R.; Fitzgerald, M. Development of nociceptive synaptic inputs to the neonatal rat dorsal horn: glutamate release by capsaicin and mentol. J. Physiol., 2003, 549, 231-242.
46. Calixto, J.B.; Kassuya, C.A.; Andre, E.; Ferreira. J. Contribution of natural products to the discovery of the transient receptor potential (TRP) channels family and their functions. Pharmacol. Ther., 2005, 106, 179-208.
47. Chizh, B.A.; O'Donnell, M.B.; Napolitano, A.; Wang, J.; Brooke, A.C.; Aylott, M.C.; Bullman, J.N.; Gray, E.J.; Lai, R.Y.; Williams, P.M.; Appleby, J.M. The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain, 2007, 132, 132-141.
48. Di Marzo, V.; Bisogno, T.; De Petrocellis, L. Anandamide: some like it hot. Trends Pharmacol. Sci., 2001, 22, 346-349.
49. Di Marzo, V.; Bisogono, T.; Petrocellis, De L.; Brandi, I.; Jefferson, R.G.; Wincler, R. L.; Davis, J.B.; Dasse, O.; Mahadevan, A.; Razdan, R.K.; Martin, B.R. Highly selective CB1 cannabinoid receptor ligands and novel CB1/VR1 vanilloid receptor "hybrid" ligands. Biochem. Biophys. Res. Commun., 2001, 281, 444-451.
50. Maione, S.; Bisogno, T.; De Novellis, V.; Palazzo, E.; Cristino, L.; Valenti, M.; Petrosino, S.; Guglielmotti, V.; Rossi, F.; Di Marzo, V. Elevation of endocannabinoid levels in the ventrolateral periaqueducal gray through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type 1 receptors. J. Pharmacol. Exp. Ther., 2006, 316, 969-982.
51. Manzanares, J.; Julian, M.D.; Carrascosa, A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr. Neuropharmacol., 2006, 4, 239-257.
52. Numazaki, M.; Tominaga M. Nociception and TRP channels. Curr. Drug Targets CNS Neurol. Disord., 2004, 3, 479-485.
53. Penuelas, A.; Tashima, K.; Tsuchiya, S.; Matsumoto, K.; Nakamura T.; Horie, S.; Yano, S. Contractile effect of TRPA1 receptor agonist in the isolated mouse intestine. Eur. J. Pharmacol., 2007, 576, 143-150.
54. Suh, Y.G.; Oh, U. Activation and activators of TRPV1 and their pharmaceutical implication. Curr. Pharm. Des., 2005, 11, 2687-2698.
55. Watanabe, H.; Murakami, M.; Ohba, T.; Takahashi, Y.; Ito, H. TRP channel and cardiovascular disease. Pharmacol. Ther., 2008, 118, 337-351.
56. Zhou, H.; Chen, S.; Chen, H.; Pan, H. The glutamatergic nature of TRPV1-expressing neurons in the spinal dorsal horn. J. Neurochem., 2009, 108, 305-318.
57. Khairatkar-Joshi, N.; Szallasi, A. TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol. Med., 2009, 15, 14-22.
58. Bang, S.; Yoo, S.; Yang, T.J.; Cho, H.; Hwang, S.W. Isopentenyl pyrophosphate is a novel antinociceptive substance that inhibits TRPV3 and TRPA1 ion channels. Pain, 2011, 152, 1165-1164.
59. De Petrocellis, L.; Vellani, V.; Schiano-Moriello, A.; Marini, P.; Magherini, P.C.; Orlando, P.; Di Marzo, V. Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8. J. Pharmacol. Exp. Ther., 2008, 325, 1007-1015.
60. Riera, C.E.; Vogel, H.; Simon, S.A.; Damak, S.; le Coutre, J. Sensory attributes of complex tasting divalent salts are mediated by TRPM5 and TRPV1 channels. J. Neurosci., 2009, 29, 2654-2662.
61. Okumura, Y.; Narukawa, M.; Iwasaki, Y.; Ishikawa, A.; Matsuda, H.; Yoshikawa, M.; Watanabe, T. Activation of TRPV1 and TRPA1 by black pepper components. Biosci. Biotechnol. Biochem., 2010, 74, 1068-1072.
62. Elitt, C.M.; Malin, S.A.; Koerber, H.R.; Davis, B.M.; Albers, K.M. Overexpression of artemin in the tongue increases expression of TRPV1 and TRPA1 in trigeminal afferents and causes oral sensitivity to capsaicin and mustard oil. Brain Res., 2008, 1230, 80-90.
63. Leffler, A.; Lattrell, A.; Kronewald, S.; Niedermirtl, F.; Nau, C. Activation of TRPA1 by membrane permeable local anesthetics. Mol. Pain, 2011, 7, 62.
64. Louhivuori, L.M.; Bart, G.; Larsson, K.P.; Louhivuori, V.; Näsman, J.; Nordström, T.; Koivisto, A.P.; Akerman, K.E. Differentiation dependent expression of TRPA1 and TRPM8 channels in IMR-32 human neuroblastoma cells. J. Cell. Physiol., 2009, 221, 67-74.
65. Gentry, C.; Stoakley, N.; Andersson, D.A.; Bevan, S. The roles of iPLA2, TRPM8 and TRPA1 in chemically induced cold hypersensitivity. Mol. Pain, 2010, 6, 4.
66. Gerhold, K.A.; Bautista, D.M. TRPA1: irritant detector of the airways. J. Physiol., 2008, 586, 3303.
67. Nagatomo, K.; Kubo, Y. Caffeine activates mouse TRPA1 channels but suppresses human TRPA1 channels. Proc. Natl. Acad. Sci. USA, 2008, 105, 17373-17378.
68. Frederick, J.; Buck, M.E.; Matson, D.J.; Cortright, D.N. Increased TRPA1, TRPM8, and TRPV2 expression in dorsal root ganglia by nerve injury. Biochem. Biophys. Res. Commun., 2007, 358, 1058-1064.
69. Kochukov, M.Y.; McNearney, T.A.; Fu, Y.; Westlund, K.N. Thermosensitive TRP ion channels mediate cytosolic calcium response in human synoviocytes. Am. J. Physiol. Cell Physiol., 2006, 291, C424-432.
70. Koo, J.Y.; Jang, Y.; Cho, H.; Lee, C.H.; Jang, K.H.; Chang, Y.H.; Shin, J.; Oh, U. Hydroxy-alpha-sanshool activates TRPV1 and TRPA1 in sensory neurons. Eur. J. Neurosci., 2007, 26, 1139-1147.
71. Narukawa, M.; Koizumi, K.; Iwasaki, Y.; Kubota, K.; Watanabe, T. Galangal pungent component, 1'-acetoxychavicol acetate, activates TRPA1. Biosci. Biotechnol. Biochem., 2010, 74, 1694-1696.
72. Crawford, D.C.; Moulder, K.L.; Gereau, R.W.; Story, G.M.; Mennerick, S. Comparative effects of heterologous TRPV1 and TRPM8 expression in rat hippocampal neurons. PLoS One, 2009, 4, e8166.
73. Hu, H.Z.; Gu, Q.; Wang, C.; Colton, C.K.; Tang, J.; Kinoshita-Kawada, M.; Lee, L.Y.; Wood, J.D.; Zhu, M.X. 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J. Biol. Chem., 2004, 279, 35741-35748.
74. Hu, H.; Tian, J.; Zhu, Y.; Wang, C.; Xiao, R.; Herz, J.M.; Wood, J.D.; Zhu, M.X. Activation of TRPA1 channels by fenamate nonsteroidal anti-inflammatory drugs. Pflugers Arch., 2010, 459, 579-592.
75. Taylor-Clark, T.E.; McAlexander, M.A.; Nassenstein, C.; Sheardown, S.A.; Wilson, S.; Thornton, J.; Carr, M.J.; Undem, B.J. Relative contributions of TRPA1 and TRPV1 channels in the activation of vagal bronchopulmonary C-fibres by the endogenous autacoid 4-oxononenal. J. Physiol., 2008, 586, 3447-3459.
76. Ta, L.E.; Bieber, A.J.; Carlton, S.M.; Loprinzi, C.L.; Low, P.A.; Windebank, A.J. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol. Pain, 2010, 6, 15.
77. Niforatos, W.; Zhang, X.F.; Lake, M.R.; Walter, K.A.; Neelands, T.; Holzman, T.F.; Scott, V.E.; Faltynek, C.R.; Moreland, R.B.; Chen, J. Activation of TRPA1 channels by the fatty acid amide hydrolase inhibitor 3'-carbamoylbiphenyl-3-yl cyclohexylcarbamate (URB597). Mol. Pharmacol., 2007, 71, 1209-1216.
78. Ikeda, Y.; Ueno, A.; Naraba, H.; Oh-ishi, S. Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice. Life Sci., 2001, 69, 2911-2919.
79. Kawao, N.; Shimada, C.; Itoh, H.; Kuroda, R.; Kawabata, A. Capsazepine inhibits thermal hyperalgesia but not nociception triggered by protease-activated receptors-2 in rats. Jpn. J. Pharmacol., 2002, 89, 184-187.
80. Maione, S.; Starowicz, K,; Cristino, L.; Guida, F.; Palazzo, E.; Luongo, L.; Rossi, F.; Marabese, I.; de Novellis, V.; Di Marzo, V. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia. J. Neurophysiol., 2009, 101, 2411-2422.
81. Meotti, F.C.; Luiz, A.P.; Pizzolatti, M.G.; Kassuya, C.A.; Calixto, J.B.; Santos, A.R. Analysis of the antinociceptive effect of the flavonoid myricitrin: Evidence for a role of the L-arginine-nitric oxide and protein kinase C pathways. J. Pharmacol. Exp. Ther., 2006, 316, 789-796.
82. Ohta, T.; Ikemi, Y.; Murakami, M.; Imagawa, T.; Otsuguro, K.; Ito, S. Potentiation of transient potential V1 functions by the activation of metabotropic 5-HT receptors in rat primary sensory neurons. J. Physiol., 2006, 576, 809-822.
83. Ohta, T.; Imagawa, T.; Ito, S. Novel gating and sensitizing mechanism of capsaicin receptor (TRPV1): tonic inhibitory regulation of extracellular sodium through the external protonation sites on TRPV1. J. Biol. Chem., 2008, 283, 9377-9387.
84. Seabrook, G.R.; Sutton, K.G.; Jarolimek, W.; Hollingworth, G.J.; Teague, S.; Webb, J.; Clark, N.; Boyce, S.; Kerby, J.; Ali, Z.; Chou, M.; Middelton, R.; Kaczorowski, G.; Jones, A.B. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodoresiniferatoxin. J. Pharmacol. Exp. Ther., 2002, 303, 1052-1060.
85. Wahl, P.; Foged, C.; Tillin, S.; Thomasen, C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol. Pharmacol., 2001, 59, 9-15.
86. Palazzo, E.; Rossi, F.; Maione, S. Role of TRPV1 receptors in descending modulation of pain. Mol. Cell. Endocrinol., 2008, 286, S79-S83.
87. Gunthorpe, M.J.; Chizh, B.A. Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway. Drug Discov. Today, 2009, 14, 56-67.
88. Kawao, N.; Ikeda, H.; Kitano, T.; Kuroda, R.; Sekiguchi F.; Kataoka, K.; Kamanaka, Y.; Kawabata, A. Modulation of capsaicinevoked visceral pain and referred hyperalgesia by proteaseactivated receptors 1 and 2. J. Pharmacol. Sci., 2004, 94, 277-285.
89. Malin, S.; Molliver, D.; Christianson, J.A.; Schwartz, E.S.; Cornuet, P.; Albers, K.M.; Davis, B.M. TRPV1 and TRPA1 function and modulation are target tissue dependent. J. Neurosci., 2011, 31, 10516-10528.
90. St Pierre, M.; Reeh, P.W.; Zimmermann, K. Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro. Exp. Brain. Res., 2009, 196, 31-44.
91. Reed, P.W.; Kress, M. Molecular physiology of proton transduction in nociceptors. Curr. Opin. Pharmacol., 2001, 1, 45-51.
92. Lambert, D.G. Capsaicin receptor antagonists: a promising new addition to the pain clinic. Br. J. Anaesth., 2009, 102, 153-155.
93. Lambert, G.A.; Davis, J.B.; Appleby, J.M.; Chizh, B.A.; Hoskin, K.L.; Zagami, A.S. The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. Naunyn Schmiedebergs Arch. Pharmacol., 2009, 380, 311-325.
94. Lehto, S.G.; Tamir, R.; Deng, H.; Klionsky, L.; Kuang, R.; Le, A.; Lee, D.; Louis, J.C; Magal, E.; Manning, B.H.; Rubino, J.; Surapaneni, S.; Tamayo, N.; Wang, T.; Wang, J.; Wang, J.; Wang, W.; Youngblood, B.; Zhang, M.; Zhu, D.; Norman, M.H.; Gavva, N.R. Antihyperalgesic effects of (R,E)-N-(2-hydroxy-2,3- dihydro-1Hinden-4-yl)-3-(2-(piperidin-1-yl)-4-(trifluoromethyl)phenyl) -acrylamide (AMG8562), a novel transient receptor potential vanilloid type 1 modulator that does not cause hyperthermia in rats. J. Pharmacol. Exp. Ther., 2008, 326, 218-229.
95. Wong, G.Y.; Gavva, N.R. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks. Brain Res. Rev., 2009, 60, 267-277.
96. Palazzo, E.; Luongo, L.; de Novellis, V.; Berrino, L.; Rossi, F.; Maione, S. Moving towards supraspinal TRPV1 receptors for chronic pain relief. Mol Pain., 2010, 6, 66.
97. Nassini, R.; Gees, M.; Harrison, S.; De Siena, G.; Materazzi, S.; Moretto, N.; Failli, P.; Preti, D.; Marchetti, N.; Cavazzini, A.; Mancini, F.; Pedretti, P.; Nilius, B.; Patacchini, R.; Geppetti. P. Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation. Pain, 2011, 152, 1621-1631.
98. http://clinicaltrials.gov/ct2/show/NCT01416116;m
99. Backonja, M.; Wallace, M.S.; Blonsky, E.R.; Cutler, B.J.; Malan, P.Jr.; Rauck, R.; Tobias, J.; NGX-4010 C116 Study Group.NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol., 2008, 7, 1106-1112.
100. Wallace, M.; Pappagallo, M. Qutenza®: a capsaicin 8% patch for the management of postherpetic neuralgia. Expert Rev. Neurother., 2011, 11, 15-27.
101. Simpson, D.M.; Gazda, S.; Brown, S.; Webster, L.R.; Lu, S.P.; Tobias, J.K.; Vanhove, G.F.; NGX-4010 C118 Study Group. Longterm safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J. Pain Symptom. Manage., 2010, 39, 1053-1064.
102. Salat, K.; Moniczewski, A.; Salat, R.; Janaszek, M.; Filipek, B.; Malawska, B.; Wieckowski, K. Analgesic, anticonvulsant and antioxidant activities of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one dihydrochloride in mice. Pharmacol. Biochem. Behav., 2012, 101, 138-147.
103. Kitagawa, Y.; Miyai, A.; Usui, K.; Hamada, Y.; Deai, K.; Wada, M.; Koga, Y.; Sakata, M.; Hayashi, M.; Tominaga, M.; Matsushita, M. Pharmacological characterization of (3S)-3-(hydroxymethyl)-4-(5-methylpyridin-2-yl)-N-[6-(2,2,2- trifluoroethoxy)pyridin-3-yl]-3,4-dihydro-2H-benzo[b][1,4]oxazine-8 carboxamide (JTS-653), a novel Transient Receptor Potential Vanilloid 1 antagonist. J. Pharmacol. Exp. Ther., 2012
104. Gavva, N.R. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol. Sci., 2008, 29, 550-557.
105. Axelsson, H.E.; Minde, J.K.; Sonesson, A.; Toolanen, G.; Högestätt, E.D.; Zygmunt, P.M. Transient receptor potential vanilloid 1, vanilloid 2 and melastatin 8 immunoreactive nerve fibers in human skin from individuals with and without Norrbottnian congenital insensitivity to pain. Neuroscience, 2009, 162, 1322-1332.
106. www.glenmarkpharma.com
107. Bang, S.; Yoo, S.; Yang, T.J.; Cho, H.; Kim, Y.G.; Hwang, S.W. Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. Br. J. Pharmacol., 2010, 161, 707-720.
108. Materazzi, S.; Fusi, C.; Benemei, S.; Pedretti, P.; Patacchini, R.; Nilius, B.; Prenen, J.; Creminon, C.; Geppetti, P.; Nassini, R. TRPA1 and TRPV4 mediate paclitaxel-induced peripheral neuropathy in mice via a glutathione-sensitive mechanism. Pflugers Arch., 2012, 463, 561-569.
109. Salas, M.M.; Hargreaves, K.M.; Akopian, A.N. TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1. Eur. J. Neurosci., 2009, 29, 1568-1578.
110. Banke, T.G.; Chaplan, S.R.; Wickenden, A.D. Dynamic changes in the TRPA1 selectivity filter lead to progressive but reversible pore dilation. Am. J. Physiol. Cell. Physiol., 2010, 298, C1457-1468.
111. Akopian, A.N.; Ruparel, N.B.; Jeske, N.A.; Hargreaves, K.M. Transient receptor potential TRPA1 channel desensitization in sensory neurons is agonist dependent and regulated by TRPV1-directed internalization. J. Physiol., 2007, 583, 175-193.
112. Staruschenko, A.; Jeske, N.A.; Akopian, A.N. Contribution of TRPV1-TRPA1 interaction to the single channel properties of the TRPA1 channel. J. Biol. Chem., 2010, 285, 15167-1577.
113. Patil, M.J.; Jeske, N.A.; Akopian, A.N. Transient receptor potential V1 regulates activation and modulation of transient receptor potential A1 by Ca2+. Neuroscience, 2010, 171, 1109-1119.
114. Chen, J.; Joshi, S.K.; DiDomenico, S.; Perner, R.J.; Mikusa, J.P.; Gauvin, D.M.; Segreti, J.A.; Han, P.; Zhang, X.F.; Niforatos, W.; Bianchi, B.R.; Baker, S.J.; Zhong, C.; Simler, G.H.; McDonald, H.A.; Schmidt, R.G.; McGaraughty, S.P.; Chu, K.L.; Faltynek, C.R.; Kort, M.E.; Reilly, R.M.; Kym, P.R. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. Pain, 2011, 152, 1165-1172.
115. Knowlton, W.M.; Bifolck-Fisher, A.; Bautista, D.M.; McKemy, D.D. TRPM8, but not TRPA1, is required for neural and behavioral responses to acute noxious cold temperatures and cold-mimetics in vivo. Pain, 2010, 150, 340-350. 1436 Current Medicinal Chemistry, 2013, Vol. 20, No. 11 Sa;at et al.
116. Forster, A.B.;Reeh, P.W.; Messlinger, K.; Fischer, M.J. High concentrations of morphine sensitize and activate mouse dorsal root ganglia via TRPV1 and TRPA1 receptors. Mol. Pain, 2009, 5, 17.
117. Dhaka, A.; Murray, A.N.; Mathur, J.; Earley, T.J.; Petrus, M.J.; Patapoutian, A. TRPM8 is required for cold sensation in mice. Neuron, 2007, 54, 371-378.
118. Knowlton, W.M.; Daniels, R.L.; Palkar, R.; McCoy, D.D.; McKemy, D.D. Pharmacological blockade of TRPM8 ion channels alters cold and cold pain responses in mice. PLoS One, 2011, 6, e25894.
119. Damann, N.; Voets, T.; Nilius, B. TRPs in our senses. Curr Biol., 2008, 18(18), R880-889. doi: 10.1016/j.cub.2008.07.063.
120. Koike, C.; Numata, T.; Ueda, H.; Mori, Y.; Furukawa, T. TRPM1: a vertebrate TRP channel responsible for retinal ON bipolar function. Cell Calcium, 2010, 48(2-3), 95-101. doi: 10.1016/j.ceca.2010.08.004.
121. Montell, C. The history of TRP channels, a commentary and reflection. Pflugers Arch., 2011, 461(5), 499-506. doi: 10.1007/s00424-010-0920-3.